Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare
Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 8, 2022
TransVoyant
|
Series Unknown | $2.95M | Analytics | Yes |
Jan 11, 2022
Transcarent
|
Series C | $200M | Health Care | — |
Dec 16, 2021
Verge Genomics
|
Series B | $98M | Biotechnology | — |
Jun 10, 2021
Transcarent
|
Series B | $58M | Health Care | — |
Feb 22, 2021
Absci
|
Corporate Round | — | Artificial Intelligence | Yes |